DUBLIN--(BUSINESS WIRE)--The "Embolic Protection Devices Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The market is growing mainly due to the rising cardiovascular and neurovascular diseases across the globe. Globally, such diseases are primarily caused by several factors, including obesity, lack of physical activities, and hypertension. Epidemiological studies have reported that cardiac and neuro diseases are recognized as the leading cause of morbidity and mortality worldwide.
Several factors influence the growth of the global embolic protection devices market. The rising demand for cerebral embolic protection devices is expected to drive the growth of the market. Growing demand for cerebral protection while performing neurovascular surgeries such as carotid artery stenting is another driving factor for the global embolic protection devices market.
The following factors are likely to contribute to the growth of the embolic protection devices market during the forecast period:
- Emergence of Advanced Embolic Protection Devices
- New Product Approvals
- Demand for Cerebral Embolic Protection Devices
The study considers the present scenario of the embolic protection devices market and its market dynamics for the period 2019-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Global Embolic Protection Devices Market Segmentation
The global embolic protection devices market research report includes a detailed segmentation by product, application, indication, end-user, and geography. The filter devices segment accounts for the maximum market share. This is due to effective clinical results for percutaneous and transcatheter surgical techniques to treat cardiac and neuro disorders. It is expected to grow at the highest CAGR owing to greater safety and procedural outcomes. The high success rate and the growing patient pool for several cardiac and neuro diseases is likely to influence segment growth. The filter devices have a larger profile than the occlusion devices segment. Availability of latest-generation devices Such as ANGIOGUARD RX Guidewire System, by Cardinal Health & FilterWire EZ by Boston Scientific, is driving the growth of the filter devices segment.
The cardiac & peripheral segment is expected to retain its market dominance during the forecast period. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiac & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe. While APAC is expected to grow at the highest CAGR, North America is likely to retain dominance in the market.
Despite potential growth opportunities of EPDs to treat saphenous vein graft (SVG), the recent eruption of the COVID-19 pandemic is causing unprecedented challenges to perform PCI procedures. The spread of the virus has disrupted daily lives with educational and commercial institutions shutting down across cities or countries and travel and large gatherings prohibited.
Healthcare professionals in hospitals use advanced embolic protection stents for cardiac & peripheral and neuro procedures. The market is growing at a healthy rate primarily due to the higher adoption of latest generation EPDs, as a majority of patients prefer to visit hospitals. The aging population and the increasing pool of patient populations with CVDs and neuro disease are the major factors driving the market growth of the hospital segment.
Key Questions Answered
1. What is the market size of the global embolic protection devices market analysis?
2. What are the factors impacting the growth of the embolic protection devices market forecast?
3. What are the drivers, trends, and restraints in the market?
4. Who are the leading vendors and what are their market shares?
Market Dynamics
Opportunities & Trends
- Emergence Of Advanced EPDs
- Promising Investigational Devices
- New Product Approval
Growth Enablers
- Rising Patient Pool
- Growing Demand For Cerebral Embolic Protection Devices
- Rising Demand For Minimally Invasive Vascular Surgeries
Restraints
- Stringent Regulations & Product Recalls
- Risk & Complications Associated With Embolic Protection Devices
- Lower Than Expected Acceptance & Clinical Implementation
Prominent Vendors
- Boston Scientific
- Abbott
- Medtronic
Other Prominent Vendors
- Cardinal Health
- Cardiovascular Systems
- Contego Medical
- InspireMD
- NIPRO
- Silk Road Medical
- Terumo
- Venus Medtech
Investigational Companies
- Cardiotimus
- Filterlex
- Innovative Cardiovascular Solutions
- Protembis
- Transverse Medical
For more information about this report visit https://www.researchandmarkets.com/r/wrnvdl
